Anchiano Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States0-1 Employees
Anchiano Therapeutics is a biopharmaceutical company focused on discovering and developing targeted cancer therapies with the aim of bringing them to market. Based in Cambridge, Massachusetts, the company operates in the biotechnology research sector and appears to run with a very small team. Its work encompasses the discovery and development of novel cancer treatments and strategies to commercialize them within the oncology field. Public reports indicate the company entered a merger with Chemomab Ltd on December 1, 2021, reflecting a notable corporate development.